_1.png)
DOTA/NOTA/H3RESCA/MAG3/DTPA/Deferoxamine/NTA/Octaaminocryptands
DOTA/NOTA/H3RESCA/MAG3/DTPA/Deferoxamine/NTA/Octaaminocryptands
DOTA, NOTA, H3RESCA, MAG3, DTPA, Deferoxamine, NTA, Octaaminocryptands and other bifunctional chelating agent derivatives, used in the research and development of medical diagnosis and treatment reagents.
-
DOTA-Tetrazine
-
DOTA
-
DO-(CH2COOH)2
-
DO-(CH2COONa)3
-
DO-(CH2COOt-Bu)2
-
DO-(CH2COOt-Bu)3
-
DOTA-(CONH2)3
-
DOTA-(COOt-Bu)3
-
DOTA-(COOt-Bu)3-azide
-
DOTA-(COOt-Bu)3-butyne
-
DOTA-(COOt-Bu)3-C2-NH2
-
DOTA-(COOt-Bu)3-C4-NH2
-
DOTA-(COOt-Bu)3-CH2-Alkynyl
-
DOTA-(COOt-Bu)3-CH2-Ph-azide
-
DOTA-(COOt-Bu)3-Mal
-
DOTA-(COOt-Bu)3-NHFmoc-Lys
-
DOTA-(COOt-Bu)3-NHS
-
DOTA mono-NHS ester
-
DOTA-4AMP
-
DOTA-Acrylamide
-
DOTA-Amide
-
DOTA-azide
-
DOTA-DBCO
-
DOTA-butyne
-
DOTA-C4-NH2
-
DOTA-CH2-Alkynyl (TFA salt)
-
DOTA-CH2-Alkynyl(HCl salt)
-
DOTA-CH2-Ph-azide (TFA salt)
-
DOTA-CH2-Ph-azide(HCl salt)
-
DOTAGA2
-
DOTAGA-(COOt-Bu)4
-
DOTA-Maleimide
-
DOTA-MeTz
-
DOTA-PEG3-azide
-
DOTA-PEG3-azide（HCl）
-
DOTA-PEG4-MeTz
-
DOTA-PEG5-amine
-
DOTA-PEG5-azide
-
DOTA-PEG5-C4-DBCO
-
DOTA-PEG8-NHCO-MeTz
-
DOTA-p-NCS-Bn
-
DOTA-p-NH2-Bn
-
DOTA-p-NH2-Bn-(COOt-Bu)4
-
DOTA-p-NH2-Bn-biotin
-
DOTA-p-NO2-Bn
-
DOTA-Serotonin
-
DOTA-SH
-
DOTATATE
-
DOT-Me-Acetic-acid
-
DOTP
-
p-NH2-Bn-oxo-DO3A
-
p-SCN-Bn-oxo-DO3A
-
(N3-PEG4)-(DOTA)-3K
-
(R)-DOTAGA-(COOt-Bu)4
-
(S)-DOTAGA-(COOt-Bu)4
-
1,1',4,4',7,7'-Hexakis(1,1-dimethylethyl) 10,10'-[(5-nitro-1,3-phenylene)bis(methylene)]-Bis[DOTA-(COOt-Bu)3]
-
1,4,7-Tris(1,1-dimethylethyl) 10-[2-[[3,5-bis(methoxycarbonyl)phenyl]amino]-2-oxoethyl]-[DOTA-(COOt-Bu)3]
-
10,10'-[(5-Nitro-1,3-phenylene)bis(methylene)]-(DOTA)2 (HCl salt)
-
10,10'-[(5-Nitro-1,3-phenylene)bis(methylene)]-(DOTA)2 (TFA salt)
-
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA (TFA salt)
-
10-[2-[(3,5-Dicarboxyphenyl)amino]-2-oxoethyl]-DOTA(HCl salt)
-
DOTA-tri(acid)-amido-PEG3-Bromoacetamide
-
Cy7.5-CONH-(C1-CONH-C2-Mal)-C4-DOTA
-
DOTA-C2-NH2(TFA salt)
-
Bromoacetamido-PEG5-DOTA
-
(S)-NOTA-GA-(COOt-Bu)3
-
NOTA
-
NOTA-(COOt-Bu)2
-
NOTA-(COOt-Bu)2-Butyne
-
NOTA-(COOt-Bu)3-Bn-NCS
-
NOTA-(COOt-Bu)2-C4-NH2
-
NOTA-Azide
-
NOTA-Bn-Mal
-
NOTA-Butyne
-
NOTA-C6-amine
-
NOTA-NHS ester
-
(R)-NOTA-GA-(COOt-Bu)3
-
NOTA-GA-Mal
-
NOTA-Maleimide
-
NOTA-PEG8-Mal
-
NOTA-Tetrazine
-
NOTA-Me-Tetrazine
-
NOTA-PEG7-N3
-
NOTA-PEG11-N3
-
NOTA-CONH-PEG23-NH-CO-CH2-CH2-Mal
-
NOTA-PEG5000-Mal
-
NOTA-p-NCS-Bn
-
NOTA-p-NH2-Bn
-
NOTP
-
NO-(COOt-Bu)2
-
NODA-GA-NHS ester
-
MeTz-PEG7-NOTA
-
MeTz-PEG11-NOTA
-
Me-Tetrazine-PEG11-NOTA
-
2-[4-(2-hydroxyethyl)-1,4,7-triazonan-1-yl]ethan-1-ol
-
NCS-MP-NODA
-
3p-C-NETA-oxa-(tBu)-butanoic acid
-
2C-p-NOTA-NCS
-
p-NOTA-NCSA
-
2C-p-NETA-NCS-Fmoc-D-赖氨酸
-
NOTA-p-NCSA-amine-PEG8-azido
-
NOTA-p-NCSA-DBCO-amine
-
NOTA-p-NCSA-Fmoc-D-赖氨酸
-
2p-C-NETA-NCS
-
2C-p-NOTA-NCS-Fmoc-D-赖氨酸
-
NOTA-p-NCSA-Me-Tetrazine-amine
-
2C-p-NETA-NCS-amine-PEG8-azido
-
2C-p-NOTA-NCS-amine-PEG8-azido
-
2C-p-NETA-NCS-DBCO-amine
-
2C-p-NETA-NCS-Me-Tetrazine-amine
-
2C-p-NOTA-NCS-DBCO-amine
-
2C-p-NOTA-NCS-Me-Tetrazine-amine
-
2,2'-(7-(2-((3-(4-Carboxy-1H-1,2,3-triazol-1-yl)propyl)amino)-2-oxoethyl)-1,4,7-triazonane-1,4-diyl)diacetic acid
-
10-[2-[(4-Hydroxy-4,4-diphosphonobutyl)amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
10-[2-Oxo-2-[[2-[(1-oxo-3,3-diphosphonopropyl)amino]ethyl]amino]ethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
10-[2-[(3,3-Diphosphonopropyl)amino]-2-oxoethyl]-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid
-
Hexahydro-α1-[3-[(4-hydroxy-4,4-diphosphonobutyl)amino]-3-oxopropyl]-1H-1,4,7-triazonine-1,4,7-triacetic acid
-
Benzamide,N-(2-aminoethyl)-2,5-bis(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)-
-
CB-Cyclam
-
CB-TE2A
-
DiAmSar
-
p-NH2-Bn-PCTA
-
p-SCN-Bn-HEHA
-
p-SCN-Bn-PCTA
-
p-SCN-Bn-TCMC
-
1,4,8,11-Tetraazacyclotetradecane-1,4,8,11-tetraacetic acid
-
2-(Benzoylthio)acetic acid
-
AMD3100(双-1,4,8,11-四氮杂环十四烷-苯甲酰)-PEG2-Mal
-
AMD3100(双-1,4,8,11-四氮杂环十四烷-苯甲酰)-PEG4-N3
-
2,5-Bis(1,4,8,11-tetraazacyclotetradec-1-ylmethyl)benzoic acid
-
2,5-bis((4,8,11-tris(tert-butoxycarbonyl)-1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzoic acid
MY ACCOUNT
Recent high-impact factor publications (IF > 10) by customers using our company's products
- Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
- A Versatile One-Step Enzymatic Strategy for Efficient Imaging and Mapping of Tumor-Associated Tn Antigen
- Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment
- Genetically Incorporated Non-Canonical Amino Acids
- Boosting Dye-Sensitized Luminescence by Enhanced Short-Range Triplet Energy Transfer
- Global profiling of functional histidines in live cells using small-molecule photosensitizer and chemical probe relay labelling
- Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling
- A proof-of-concept study on bioorthogonal-based pretargeting and signal amplify radiotheranostic strategy
- Bioengineered Platelets Combining Chemotherapy and Immunotherapy for Postsurgical Melanoma Treatment: Internal Core-Loaded Doxorubicin and External Surface-Anchored Anti-PDL1 Antibody Backpacks
- Scalable Synthesis of Highly Stable Cyclopropene Building Blocks: Application for Bioorthogonal Ligation with Tetrazines
- Noncanonical amino acids as doubly bio-orthogonal handles for one-pot preparation of protein multiconjugates
- Reversible control of tetrazine bioorthogonal reactivity by naphthotube-mediated host-guest recognition
- An Optimized Isotopic Photocleavable Tagging Strategy for SiteSpecific and Quantitative Profiling of Protein O‑GlcNAcylation in Colorectal Cancer Metastasis
Xi'an Dianhua Biotechnology Co., Ltd. is the exclusive agent for our company's products and has been listed on the following reagent procurement platforms.
You can directly click on the corresponding link to place an order.
